Benefits of Testing
Early testing is the key to better care and more time
Early detection of elevated p-tau217 offers meaningful benefits for managing cognitive changes related to Alzheimer’s disease. Identifying these early signals gives you and your loved ones the time and clarity to make informed decisions, plan for the future, and access the right medical guidance and support. By understanding your brain health sooner, you gain a proactive advantage in protecting memory and overall cognitive wellness.
The Difference Early Testing Can Make
Understanding the benefits of testing for Alzheimer’s disease provides crucial insights that empower informed decisions, proactive planning, and strategies to maintain quality of life for you and your loved ones.
Take Action Years Earlier
Our p-tau217 blood test, combined with a brief cognitive assessment, offers predictive insights into brain health. Together, they create a clear baseline for understanding cognitive function and help guide follow-up care with confidence.
Support Healthy Brain Function
Early detection enables collaboration with healthcare providers on evidence-based medical approaches and lifestyle strategies. Research shows that lifestyle changes can delay disease progression by up to 60%, while disease-modifying treatments for Alzheimer’s can slow progression by about 45% when started early. Taking action sooner empowers you to protect cognitive health and maintain quality of life longer.
Maintain Independence Longer
With earlier awareness, you gain more time to create personalized care plans, build support networks, and adopt strategies that help preserve independence and overall quality of life. Early insight equips you to approach the future proactively, rather than reactively.
Am I a Good Candidate for Testing?
As we age, the risk of Alzheimer’s disease increases. Understanding the benefits of testing for Alzheimer’s disease can help adults 50 and older, and those with additional risk factors, take proactive steps to understand their brain health and plan for the future.
People Experiencing Memory Issues or Cognitive Changes
This includes challenges such as occasional confusion, difficulty with problem-solving, trouble keeping track of time or place, or frequent memory lapses. Early testing can provide clarity and guidance.
Adults Aged 50 and Older
Age is the most significant risk factor for Alzheimer’s, especially when combined with conditions like heart disease, diabetes, or high blood pressure. Testing offers an early window into cognitive health before noticeable symptoms appear.
Individuals with a Family History
Genetics can increase the likelihood of developing Alzheimer’s or other dementias. For adults over 40 with a family history of Alzheimer’s, testing can provide valuable early insights and support proactive planning with healthcare providers.
Empowering Action
Neurogen provides a complete ecosystem to support early detection of Alzheimer’s disease and guide proactive cognitive health planning. By acting now, you create the opportunity for better outcomes, more options, and a stronger future.
Early Testing
The Neurogen At-Home Test Kit combines advanced p-tau217 testing, a blood biomarker linked to Alzheimer’s disease, with a brief online cognitive assessment. Together, they deliver a comprehensive view of your brain health from the comfort of home, providing insight years before severe symptoms appear.
After receiving your kit, a nurse or health professional will guide you through the sample collection process to ensure accuracy and comfort.
Dedicated Neurologist
If your results indicate potential cognitive changes, a board-certified neurologist will review your findings during a telehealth consultation. You’ll receive expert guidance and next-step recommendations tailored to your unique situation.
Personalized Brain Action Plan
Based on your test results and health profile, you receive a customized Brain Action Plan. This plan provides actionable strategies to support cognitive health, empowering you to make informed lifestyle choices and care decisions for yourself or your loved ones.
“Understanding the cause of cognitive impairment at the earliest possible time is critical for identifying the most appropriate treatment pathways. The combination of Neurogen’s blood-based biomarker and ecosystem for explanation of results and care can make a big difference in patient’s treatment plans.”
- Dr. Michelle Mielke
Professor of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine